<DOC>
	<DOCNO>NCT00477672</DOCNO>
	<brief_summary>This study evaluate safety efficacy two dose level pimavanserin ( ACP-103 ) compare placebo patient Parkinson 's disease psychosis .</brief_summary>
	<brief_title>A Study Safety Efficacy Pimavanserin ( ACP-103 ) Patients With Parkinson 's Disease Psychosis</brief_title>
	<detailed_description />
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Mental Disorders</mesh_term>
	<mesh_term>Pimavanserin</mesh_term>
	<criteria>A clinical diagnosis Parkinson 's disease minimum duration 1 year Presence visual and/or auditory hallucination , and/or delusion , occur four week prior study screen Psychotic symptom must develop PD diagnosis establish Subject must stable dose antiParkinson 's medication 1 month prior Study Day 1 ( Baseline ) trial Subject receive stereotaxic surgery subthalamic nucleus deep brain stimulation must least 6 month post surgery stimulator setting must stable least 1 month prior Study Day 1 ( Baseline ) must remain stable trial The subject willing able provide consent Caregiver willing able accompany subject visit Subject history significant psychotic disorder prior concomitantly diagnosis Parkinson 's disease include , limited , schizophrenia bipolar disorder Subject receive previous ablative stereotaxic surgery ( i.e. , pallidotomy thalamotomy ) treat Parkinson 's disease Subject current evidence serious unstable cardiovascular , respiratory , gastrointestinal , renal , hematologic medical disorder Subject myocardial infarction last six month Subject surgery plan screening , treatment followup period Patients evaluate screening ensure criterion study participation met . These evaluation include specific measure psychosis severity , delirium , dementia , cardiovascular condition , pregnancy status . Patients may exclude study base assessment ( specifically determine baseline health psychiatric condition meet protocolspecified entry criterion ) .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>Parkinson 's disease , psychotic disorder</keyword>
</DOC>